The Effects of Faculty/Staff Exercise Program

Physical Activity Clinical Trial

Official title:

The Physiological and Cognitive Effects of Faculty/Staff Exercise Program in a University Setting

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03385447
• Other study ID #: 13-329
• Status: Completed
• Phase: N/A
• First received: December 4, 2017
• Last updated: December 20, 2017
• Start date: June 26, 2013
• Est. completion date: October 11, 2013

Study information

• Verified date: December 2017
• Source: Kent State University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study focuses on analyzing the data collected from participants in the Faculty/Staff Exercise Program to determine the success and quantifying the results of the program. The investigators are interested in the effectiveness of this program on multiple levels, individual and group, as it is the first of its kind - an exercise program targeting the faculty and staff at a university.

Description:

This study focuses on analyzing the data collected from participants in the Faculty/Staff Exercise Program to determine the success and quantifying the results of the program. The investigators are interested in the effectiveness of this program on multiple levels, individual and group, as it is the first of its kind - an exercise program targeting the faculty and staff at a university. Participants were regular attendees in either a 6am or 12pm exercise program session. Data included both measures of physical health as well as cognitive health. Measures of physical health included the assessment of body fat using the skin-fold method of analysis (3-site). Cholesterol was measured via blood draw analysis. This was done at the Kent State University Exercise Physiology Laboratory by certified research staff. A 6 minute walk test was completed to measure aerobic capacity. Flexibility was assessed via the sit-and-reach test while anaerobic strength and endurance were assessed using sit-up and curl-up tests. Assessment of balance was done using a Biodex Balance System.

Assessments of cognitive health included several questionnaires that asked questions related to sleep habits, stress levels, and mood. In addition, each participant was given a MOVband to track physical activity. The device was worn during waking hours for all days of participation.The data from the MOVband was auto-uploaded to a computer program for tracking so that no manual entry was necessary.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: October 11, 2013
• Est. primary completion date: October 11, 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years to 65 Years

Eligibility

Inclusion Criteria:

• age 21-65 years

• current faculty/staff member

• no contraindications to exercise

• sedentary prior to enrollment

Exclusion Criteria:

• age <21 years, >65 years

• non faculty/staff member

• contraindications to exercise

• regular exercise participation prior to enrollment

Related Conditions & MeSH terms

• Cardiovascular Risk Factor
• Physical Activity
• Sedentary Lifestyle

Intervention

Behavioral:
• Physical Activity
Participants underwent 12-weeks of exercise prescription aimed at the federal guidelines (3 days/week).

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Kent State University

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Sleep Quality (Pittsburgh Sleep Quality Index)	The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval.	Change from baseline sleep quality at 4-weeks, 8-weeks, and 12-weeks follow-up.
Other	Depression (Depression, Anxiety, and Stress Scale-21)	The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress.	Change from baseline depression at 4-weeks, 8-weeks, and 12-weeks follow-up.
Other	Anxiety (Depression, Anxiety, and Stress Scale-21)	The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress.	Change from baseline anxiety at 4-weeks, 8-weeks, and 12-weeks follow-up.
Other	Stress (Depression, Anxiety, and Stress Scale-21)	The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress.	Change from baseline stress at 4-weeks, 8-weeks, and 12-weeks follow-up.
Other	Mood (Profile of Mood States)	The Profile of Mood States (POMS) is a psychological rating scale used to assess transient, distinct mood states.	Change from baseline mood at 4-weeks, 8-weeks, and 12-weeks follow-up.
Other	Quality of Life (36-Item Short Form Survey)	The 36-item short form survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures.	Change from baseline quality of life at 4-weeks, 8-weeks, and 12-weeks follow-up.
Primary	Height	Objectively measured height in meters using a standard clinical stadiometer.	Assessed once at baseline.
Primary	Weight	Objectively measured weight in kilograms using a standard clinical scale.	Change from baseline weight at 4-weeks, 8-weeks, and 12-weeks follow-up.
Primary	Systolic Blood Pressure	Objectively measured systolic blood pressure in millimeters of Mercury using a standard Mercury sphygmomanometer.	Change from baseline systolic blood pressure at 4-weeks, 8-weeks, and 12-weeks follow-up.
Primary	Diastolic Blood Pressure	Objectively measured diastolic blood pressure in millimeters of Mercury using a standard Mercury sphygmomanometer.	Change from baseline diastolic blood pressure at 4-weeks, 8-weeks, and 12-weeks follow-up.
Primary	High-Density Lipoprotein	Objectively measured high-density lipoprotein in milligrams per deciliter using a standard assay kit.	Change from baseline high-density lipoprotein at 4-weeks, 8-weeks, and 12-weeks follow-up.
Primary	Low-Density Lipoprotein	Objectively measured low-density lipoprotein in milligrams per deciliter using a standard assay kit.	Change from baseline low-density lipoprotein at 4-weeks, 8-weeks, and 12-weeks follow-up.
Primary	Total Serum Cholesteral	Objectively measured total serum cholesterol in milligrams per deciliter using a standard assay kit.	Change from baseline total serum cholesterol at 4-weeks, 8-weeks, and 12-weeks follow-up.
Primary	Impaired Fasting Glucose	Objectively measured impaired fasting glucose in milligrams per deciliter using a standard assay kit.	Change from baseline impaired fasting glucose at 4-weeks, 8-weeks, and 12-weeks follow-up.
Secondary	Accelerometer-Based Physical Activity	Assessment of accelerometer-based physical activity outcome measures (e.g., steps per day).	Change from baseline accelerometer-based physical activity 4-weeks, 8-weeks, and 12-weeks follow-up using 1-minute epochs.